Lysosomal Storage Disease Market: How Is Personalized Medicine and...

added blog Botanik

2026-05-30 11:03:11

Lysosomal Storage Disease Market: How Is Personalized Medicine and Genetic Stratification Transforming LSD Treatment?

Personalized medicine's LSD treatment transformation through genetic stratification — the progressive shift in lysosomal storage disease management from uniform enzyme replacement therapy toward genotype-guided treatment selection — where specific pathogenic variants determine treatment eligibility (migalastat in Fabry disease requiring amenable mutations), predict disease severity...

0 Comments 0 Shares 15 Views 0 Reviews